Despite the limited amount of CSF cfDNA, mutations and most relevant genomic alterations identified in the tumour were also detected in the CSF ctDNA, including MYCN and GLI2 amplification, and partial loss of 17p (Fig. 5e, f and Fig. 3e). Here, GLI2 is linked to neoplasm.